SCHEMBL13636272

SCHEMBL13636272

CC(C)(C)OC(=O)NN(C=O)c1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.41
CTSS P25774 3/20 0.38
CTSL P07711 2/20 0.38
CTSB P07858 2/20 0.38
CTSK P43235 1/20 0.37
MAPK10 P53779 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
EPHX2 P34913 1/20 0.35
RAB9A P51151 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
NPC1 O15118 2/20 0.35
GAA P10253 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
ATM Q13315 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13636269 0.83 AKT1 (0.44) AKT1CTSSCTSLCTSBMAPK10
SCHEMBL13635931 0.76 AKT1 (0.36) AKT1MEN1KMT2ACA12CA1
SCHEMBL4375001 0.73 AKT1 (0.42) AKT1CTSSCTSLCTSBCTSK
SCHEMBL15135380 0.71 AKT1 (0.45) AKT1CTSSCTSLCTSBCTSK
SCHEMBL30568129 0.70 PAX8 (0.41) CTSSCTSKRAB9AMEN1KMT2A
SCHEMBL23218018 0.69 LMNA (0.40) AKT1CTSSCTSKLMNAPOLB
SCHEMBL4931101 0.69 RIPK1 (0.36) CTSSCTSKLMNAPOLBKMT2A
SCHEMBL4364528 0.69 AKT1 (0.40) AKT1CTSSCTSLCTSBCTSK
SCHEMBL4413477 0.69 AKT1 (0.40) AKT1CTSSCTSLCTSBRAB9A
SCHEMBL661640 0.68 RAB9A (0.56) LMNAPOLBRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622492-B2 Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase HOFFMANN-LA ROCHE INC. (US) 2009-11-24 US disclosed
US-20070049632-A1 Pyrazolones as inhibitors of 11B-hydroxysteroid dehydrogenase BANNER BRUCE L 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049632-A1 Pyrazolones as inhibitors of 11B-hydroxysteroid dehydrogenase HSD17B1, HSD17B2, HSD3B2 AKT1 1050/4885CTSS 3304/4885CTSL 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.